Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 23;52(17):10533-10542.
doi: 10.1093/nar/gkae695.

Chemical synthesis of 2″OMeNAD+ and its deployment as an RNA 2'-phosphotransferase (Tpt1) 'poison' that traps the enzyme on its abortive RNA-2'-PO4-(ADP-2″OMe-ribose) reaction intermediate

Affiliations

Chemical synthesis of 2″OMeNAD+ and its deployment as an RNA 2'-phosphotransferase (Tpt1) 'poison' that traps the enzyme on its abortive RNA-2'-PO4-(ADP-2″OMe-ribose) reaction intermediate

Jakob Arnold et al. Nucleic Acids Res. .

Abstract

RNA 2'-phosphotransferase Tpt1 catalyzes the removal of an internal RNA 2'-PO4 via a two-step mechanism in which: (i) the 2'-PO4 attacks NAD+ C1″ to form an RNA-2'-phospho-(ADP-ribose) intermediate and nicotinamide; and (ii) transesterification of the ADP-ribose O2″ to the RNA 2'-phosphodiester yields 2'-OH RNA and ADP-ribose-1″,2″-cyclic phosphate. Although Tpt1 enzymes are prevalent in bacteria, archaea, and eukarya, Tpt1 is uniquely essential in fungi and plants, where it erases the 2'-PO4 mark installed by tRNA ligases during tRNA splicing. To identify a Tpt1 'poison' that arrests the reaction after step 1, we developed a chemical synthesis of 2″OMeNAD+, an analog that cannot, in principle, support step 2 transesterification. We report that 2″OMeNAD+ is an effective step 1 substrate for Runella slithyformis Tpt1 (RslTpt1) in a reaction that generates the normally undetectable RNA-2'-phospho-(ADP-ribose) intermediate in amounts stoichiometric to Tpt1. EMSA assays demonstrate that RslTpt1 remains trapped in a stable complex with the abortive RNA-2'-phospho-(ADP-2″OMe-ribose) intermediate. Although 2″OMeNAD+ establishes the feasibility of poisoning and trapping a Tpt1 enzyme, its application is limited insofar as Tpt1 enzymes from fungal pathogens are unable to utilize this analog for step 1 catalysis. Analogs with smaller 2″-substitutions may prove advantageous in targeting the fungal enzymes.

PubMed Disclaimer

Figures

Graphical Abstract
Graphical Abstract
Figure 1.
Figure 1.
Tpt1 mechanism. (A) The Tpt1 reaction pathway comprises the two chemical steps shown in which: (1) an RNA 2′-PO4 oxygen attacks the C1″ atom of NAD+ to expel nicotinamide and form a 2′-phospho-ADP-ribosylated RNA intermediate and (2) transesterification of the ADP-ribose 2″-OH to the RNA 2′-PO4 displaces the RNA 2′-OH and generates ADP-ribose-1″,2″-cyclic phosphate. (B) 2″OMeNAD+ is an NAD+ analogue in which the ribose 2″-OH is replaced by a 2″-OMe group that should not serve as a nucleophile for step 2 transesterification.
Figure 2.
Figure 2.
Synthesis of 2′OMe-nicotinamide riboside (compound 5) using TMS-OTf mediated glycosylation. (A) (a) Iodomethane, Ag2O, dimethylformamide, 80°C, 18 h, 84%. (b) tetrabutylammonium fluoride, tetrahydrofurane, r.t., 17 h; then acetic anhydride, pyridine, r.t., 19 h, 90% over two steps. (c) acetic acid, acetic anhydride, H2SO4, 10°C, 16 h, 71%. (d) nicotinamide, compound 4, acetonitrile, then TMS-triflate, r.t., 4 h. (e) nicotinamide, TMS-triflate, acetonitrile, r.t. 30 min, then compound 4, r.t., 4 h; then NH3 in methanol, r.t., 18 h, 28% over two steps; (B) 1H-13C-HMBC NMR spectrum of compound 5-R, with highlighted cross signal between 1′-H and C-carbonyl. (C) 1H-13C-HMBC NMR spectrum of compound 5 showing the absence of the carbonyl-correlation and instead a cross signal between 1′-H and C-2 and 1H-1H NOESY spectrum of compound 5 with highlighted nuclear overhauser effects (NOEs) between 1′-H and 4′-H and 3′-H and aromatic protons.
Figure 3.
Figure 3.
Synthesis of 2″OMeNAD+ (compound 7). (A) POCl3, trimethylphosphate, 0°C, 4 h, 50 %; (B) AMP P-imidazolide, MgCl2, formamide, r.t., 24 h, 48%.
Figure 4.
Figure 4.
Utilization of 2″OMeNAD+ by Runella Tpt1 generates a dead-end 2′-phospho-ADP-ribosylated RNA. (A) Tpt1 titrations. Reaction mixtures (10 μl) containing 100 mM Tris–HCl (pH 7.5), 0.2 μM (2 pmol) 5′ 32P-labeled 6-mer 2′-PO4 substrate, either 50 μM NAD+ (left panel), no added NAD+ (middle panel), or 50 μM 2″OMeNAD+ (middle panel), and RslTpt1 as specified on the x-axes were incubated at 37°C for 30 min. The extents of formation of 2′-OH end-product and abortive 2′-P-ADPR intermediate are plotted as a function of input Tpt1. Each datum in the graphs is the average of three independent titration experiments ± SEM. (B) Kinetics of the reaction with 2″OMeNAD+. Reaction mixtures (100 μl) containing 100 mM Tris–HCl (pH 7.5), 0.2 μM 5′ 32P-labeled 6-mer 2′-PO4 substrate, 50 μM 2″OMeNAD+, and 0.5 μM RslTpt1 were incubated at 37°C. The reactions were initiated by adding RslTpt1 to a pre-warmed reaction mixture. Aliquots (10 μl, containing 2 pmol of 2′-PO4 RNA substrate) were withdrawn at the times specified on the x-axis and quenched immediately with cold formamide/EDTA. The extents of formation of 2′-P-ADPR RNA and 2′-OH RNA are plotted as a function of reaction time. Each datum in the graphs is the average of three independent time course experiments ± SEM. The data were fit by nonlinear regression to a one phase association in Prism.
Figure 5.
Figure 5.
2″OMeNAD+ traps Tpt1 on the RNA-2′-phospho-(ADP-2″OMe-ribose) dead-end product. (A) Reaction mixtures (10 μl) containing 100 mM Tris–HCl (pH 7.5), 0.2 μM (2 pmol) 5′ 32P-labeled 6-mer 2′-PO4 substrate, either no added NAD+, 50 μM NAD+, or 50 μM 2″OMeNAD+, and 5 pmol RslTpt1 (where indicated by + above the lanes) were incubated at 37°C for 15 min. The mixtures were adjusted to 5% (v/v) glycerol and then applied to a 15-cm native 8% polyacrylamide gel containing 0.25x TBE that had been pre-run at 110 V for 30 min. Separation of RslTpt1-bound and free RNA was achieved by electrophoresis for 2.5 h at 110 V at room temperature. The radiolabeled species were visualized by scanning the gel with a Typhoon FLA-7000 imaging device. The positions of the sample well and xylene cyanol (XC) and bromophenol blue (BPB) dye makers run in a parallel lane are indicated on the right. (B) Reaction mixtures (10 μl) containing 100 mM Tris–HCl (pH 7.5), 0.2 μM (2 pmol) 5′ 32P-labeled 6-mer 2′-PO4 substrate, 50 μM 2″OMeNAD+ and RslTpt1 as specified above the lanes were incubated at 37°C for 15 min, adjusted to 5% glycerol, and then analyzed by native PAGE.
Figure 6.
Figure 6.
2″OMeNAD+ is not an effective substrate for Tpt1 from three fungal pathogens. Reaction mixtures (10 μl) containing 100 mM Tris–HCl (pH 7.5), 0.2 μM (2 pmol) 5′ 32P-labeled 6-mer 2′-PO4 substrate, either 50 μM NAD+ or 50 μM 2″OMeNAD+ (where indicated by +), and 0.5 μM (5 pmol) Tpt1 from the species specified on the x-axis were incubated at 37°C for 30 min. The extents of formation of 2′-OH RNAs in reactions containing NAD+ (blue bars) and formation of RNA-2′-phospho-(ADP-2″OMe-ribose) in reactions containing 2″OMeNAD+ (red bars) are shown. Data are the average of three independent experiments ± SEM.

References

    1. Suskiewicz M.J., Prokhorova E., Rack J.G., Ahel I.. ADP-ribosylation from molecular mechanisms to therapeutic implications. Cell. 2023; 186:4475–4495. - PMC - PubMed
    1. Sauve A.A., Youn D.Y.. Sirtuins: NAD+-dependent deacetylase mechanism and regulation. Curr. Opin. Chem. Biol. 2012; 16:535–543. - PubMed
    1. Bursch K.L., Goetz C.J., Smith B.C.. Current trends in sirtuin activator and inhibitor development. Molecules. 2024; 29:1185. - PMC - PubMed
    1. Culver G.M., McCraith S.M., Consaul S.A., Stanford D.R., Phizicky E.M.. A 2′-phosphotransferase implicated in tRNA splicing is essential in Saccharomyces cerevisiae. J. Biol. Chem. 1997; 272:13203–13210. - PubMed
    1. Spinelli S.L., Malik H.S., Consaul S.A., Phizicky E.M.. A functional homolog of a yeast tRNA splicing enzyme is conserved in higher eukaryotes and in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 1998; 95:14136–14141. - PMC - PubMed

LinkOut - more resources